Digital healthcare startup Medipal (CEO Kang Jong-il) announced on the 5th that it has signed a contract with Incheon Sejong Hospital (Chairman Park Jin-sik) to supply 'Afterdoc', a B2B SaaS solution for managing hospital patients.
Afterdoc is a solution that automates customized prognosis management by continuously communicating with patients after treatment. It builds a consultation system tailored to each patient's treatment characteristics and cycle, thereby increasing treatment effectiveness and patient satisfaction, and provides hospitals and clinics with increased sales through increased revisit rates.
Incheon Sejong Hospital, a general hospital under the Hyewon Medical Foundation, opened in 2017 and provides specialized medical services through five specialized centers, including a cardiac specialty hospital. In 2020, it was the only general hospital in the Incheon area selected to implement the Ministry of Health and Welfare's "Home Healthcare Pilot Project for Heart Disease Patients." Recently, the hospital has been focusing on patient-centered care innovation through the introduction of digital healthcare.
Through this collaboration, MediPal plans to expand Afterdoc's follow-up patient management system to all departments at Incheon Sejong Hospital and expand its customer base to mid- to large-sized hospitals.
Incheon Sejong Hospital Chairman Park Jin-sik stated, “We have been striving to provide efficient and high-quality medical services, and by introducing Afterdoc, we will strengthen our patient management system and increase trust between medical staff and patients.”
MediPal CEO Kang Jong-il said, “We expect this introduction to expand Afterdoc’s aftercare service area, and we will focus on developing digital healthcare technology to contribute to creating a sustainable medical environment.”
- See more related articles
You must be logged in to post a comment.